Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 (e-bog) af -
Ahmad, Sarfraz (redaktør)

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3 e-bog

1386,89 DKK (inkl. moms 1733,61 DKK)
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatme...
E-bog 1386,89 DKK
Forfattere Ahmad, Sarfraz (redaktør)
Udgivet 15 april 2022
Længde 468 sider
Genrer Operational research
Sprog English
Format pdf
Beskyttelse LCP
ISBN 9780323992848
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma: Translational and Clinical Outcomes, Volume Three provides comprehensive information about ongoing research and clinical data on liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. This updated volume discusses topics such as clinical and safety assessment of HCC patients, liver transplantation as a therapeutic option, immunotherapy interventions, and image-based surveillance. In addition, it discusses immunohistology of HCC-enabled precision medicine and artificial intelligence for hepatocellular carcinomas. This is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting. Provides best practices for the management of hepatocellular carcinoma in the clinical setting Discusses emerging treatment approaches based on artificial intelligence and precision medicine tools and techniques Brings updated information on international clinical trials for the treatment of HCC